Zhaoyu Ning

机构：Fujian Medical University, Mengchao Hepatobiliary Hospital, Fuzhou University

发表论文 3 篇 · 总被引 49 次 · h-index 3

代表论文

• CD16/PD-L1 bi-specific aptamer for cancer immunotherapy through recruiting NK cells and acting as immunocheckpoint blockade (2022 · Molecular Therapy — Nucleic Acids · 被引 26)
• Human serum albumin as the carrier to fabricate STING-activating peptide nanovaccine for antitumor immunotherapy (2024 · Materials Today Bio · 被引 13)
• Biodegradable MnO2-based gene-engineered nanocomposites for chemodynamic therapy and enhanced antitumor immunity (2022 · Materials Today Bio · 被引 10)